Cargando…

Gastrointestinal toxicities associated with immune checkpoint inhibitors: a disproportionality analysis leveraging VigiBase, the WHO Adverse Drug Reaction Database

With the improvement of people's living standards, gastrointestinal adverse reactions caused by various adverse factors have attracted more and more people's attention. A recent study has indicated that coronavirus disease 2019 (COVID-19) could also invade the gastrointestinal tract, leadi...

Descripción completa

Detalles Bibliográficos
Autores principales:	HUANG, Sifu, BAI, Xuefeng, FANG, Taiyong, GUO, Yanta, ZHENG, Kainan, LIN, Xiahong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Zhejiang University Press 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885752/ https://www.ncbi.nlm.nih.gov/pubmed/33615756 http://dx.doi.org/10.1631/jzus.B2000449

Ejemplares similares

Mapping endocrine toxicity spectrum of immune checkpoint inhibitors: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase
por: Bai, Xuefeng, et al.
Publicado: (2020)

Adverse Event Reporting with Immune Checkpoint Inhibitors in Older Patients: Age Subgroup Disproportionality Analysis in VigiBase
por: Noseda, Roberta, et al.
Publicado: (2021)

Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase
por: Calapai, Fabrizio, et al.
Publicado: (2023)

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database
por: Gastaldon, C., et al.
Publicado: (2023)

Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase
por: Noseda, Roberta, et al.
Publicado: (2021)

VigiAccess: Promoting public access to VigiBase
por: Shankar, Pathiyil Ravi
Publicado: (2016)

Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
por: Sandberg, Lovisa, et al.
Publicado: (2020)

Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase
por: Willemen, Marjolein J., et al.
Publicado: (2011)

Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase
por: Man, Wai Hong, et al.
Publicado: (2020)

Reporting Antimicrobial-Related Adverse Drug Events in Jordan: An Analysis from the VigiBase Database
por: Mhaidat, Nizar Mahmoud, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase(®) Spontaneous Reporting System
por: Noseda, Roberta, et al.
Publicado: (2022)

The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase(®)
por: Matlala, Mafora F., et al.
Publicado: (2023)

Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database
por: Pochet, Stéphanie, et al.
Publicado: (2022)

Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines
por: Dutta, Siddhartha, et al.
Publicado: (2022)

Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports
por: Wakao, Rika, et al.
Publicado: (2019)

Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase(®)
por: Vogel, Ulrich, et al.
Publicado: (2020)

Ocular surface disorders associated with the use of dupilumab based on WHO VigiBase
por: Park, Sunny, et al.
Publicado: (2021)

Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase
por: Zhang, Qingxia, et al.
Publicado: (2022)

Montelukast and Nightmares: Further Characterisation Using Data from VigiBase
por: Watson, Sarah, et al.
Publicado: (2022)

Infections associated with clozapine: a pharmacovigilance study using VigiBase(®)
por: Chrétien, Basile, et al.
Publicado: (2023)

Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites
por: Juhlin, Kristina, et al.
Publicado: (2015)

Characterization of VigiBase reports on tinnitus associated with bisoprolol—An exploratory and descriptive study
por: Watson, Sarah, et al.
Publicado: (2021)

Short communication: Comments on hair disorders associated with dupilumab based on VigiBase
por: Park, Sunny, et al.
Publicado: (2022)

Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase(®))
por: Duga, Alemayehu Lelisa, et al.
Publicado: (2023)

Fatal Adverse Events of Dabigatran Combined With Aspirin in Elderly Patients: An Analysis Using Data From VigiBase
por: Zhang, Qingxia, et al.
Publicado: (2021)

Pre-Existing Cardiovascular Conditions as Clinical Predictors of Myocarditis Reporting with Immune Checkpoint Inhibitors: A VigiBase Study
por: Noseda, Roberta, et al.
Publicado: (2020)

Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports
por: Sultana, Janet, et al.
Publicado: (2020)

Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase
por: Fernandez, Silvia, et al.
Publicado: (2021)

A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization
por: Jeong, Han Eol, et al.
Publicado: (2022)

Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase(®)
por: Sessa, Maurizio, et al.
Publicado: (2019)

Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020
por: Rocca, Elena, et al.
Publicado: (2021)

A VigiBase Descriptive Study of Fluoroquinolone-Associated Peripheral Nervous System Disorders
por: Huruba, Madalina, et al.
Publicado: (2022)

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
por: Gatti, Milo, et al.
Publicado: (2021)

Renal Safety Profile of EGFR Targeted Therapies: A Study from VigiBase(®) the WHO Global Database of Individual Case Safety Reports
por: Crosnier, Alexandre, et al.
Publicado: (2021)

Suspected cutaneous adverse drug reactions reported with traditional medicines: analysis of data for United Nations Asia region from WHO VigiBase
por: Barvaliya, Manish J., et al.
Publicado: (2023)

Adverse Drug Reaction Onsets in Uganda’s VigiBase(®): Delayed International Visibility, Data Quality and Illustrative Signal Detection Analyses
por: Kiguba, Ronald, et al.
Publicado: (2018)

Valproic Acid and Fatalities in Children: A Review of Individual Case Safety Reports in VigiBase
por: Star, Kristina, et al.
Publicado: (2014)

Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase(®)
por: Chandler, Rebecca E., et al.
Publicado: (2016)

Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre
por: Star, Kristina, et al.
Publicado: (2019)

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study
por: Garcia, Philippe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_faotmulukbktg5ndo1ugjgft8r